Genetic Technologies’ COVID-19 Risk Test Now Available in US through Partnership with Infinity BiologiX
01 juin 2021 08h00 HE
|
Genetic Technologies Ltd
Key Highlights: Gene’s COVID-19 Risk Test released for sale in the US through IBXDesigned to predict disease severity to assist in informing decisions about disease risk, treatment options and...
Genetic Technologies Interview to Air on Bloomberg Television U.S. on the RedChip Money Report®
13 mai 2021 09h01 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, May 13, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics and AI driven preventative health business,...
Genetic Technologies’ COVID-19 Risk Test Approved for Commercial Release
26 avr. 2021 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, April 26, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics and AI driven preventative health business...
Genetic Technologies appoints Mike Tonroe as CFO
12 avr. 2021 08h15 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, April 12, 2021 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”), announces the appointment of Michael Tonroe...
Genetic Technologies Provides Update on COVID-19 Risk Test Launch
09 avr. 2021 11h15 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, April 09, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics and AI driven preventative health business...
Genetic Technologies Signs Multi-Year US Distribution Agreement for COVID Risk Test
04 mars 2021 07h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, March 04, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics and AI-driven preventative health business is...
Genetic Technologies Limited Interview to Air on Bloomberg TV in the US on the RedChip Money Report®
26 févr. 2021 09h20 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today...
Genetic Technologies Announces Closing of $6.56 Million Registered Direct Offering
25 janv. 2021 16h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today...
Genetic Technologies Announces $6.56 Million Registered Direct Offering
21 janv. 2021 11h30 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today...
Genetic Technologies Provides Update on its COVID-19 Disease Severity Risk Test and Expansion into Germline Testing
21 janv. 2021 07h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”), provides the following update to the market on...